NCT02509975View on ClinicalTrials.gov

Safety and Efficacy of OCL 503 in Prostate Artery Embolization

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Benign Prostatic HyperplasiaBenign Prostatic Hypertrophy
Interventions
DEVICE

Prostate artery embolization.

Embolization of the prostatic vasculature with OCL 503 using a microcatheter.

Trial Locations (1)

T6G 2B7

University of Alberta Hospital, Edmonton

Sponsors
All Listed Sponsors
lead

IMBiotechnologies Ltd.

INDUSTRY